Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Feb;19(2):213-25.
doi: 10.1517/14728222.2014.978860. Epub 2015 Jan 2.

The SIX1-EYA transcriptional complex as a therapeutic target in cancer

Melanie A Blevins  1 , Christina G Towers, Aaron N Patrick, Rui Zhao, Heide L Ford
Affiliations
Review

The SIX1-EYA transcriptional complex as a therapeutic target in cancer

Melanie A Blevins et al. Expert Opin Ther Targets. 2015 Feb.

Abstract

Introduction: The SIX homeodomain proteins and the eyes absent (EYA) family of co-activators form a bipartite transcription factor complex that promotes the proliferation and survival of progenitor cells during organogenesis and is down-regulated in most adult tissues. Abnormal over-expression of SIX1 and EYA in adult tissue is associated with the initiation and progression of diverse tumor types. Importantly, SIX1 and EYA are often co-overexpressed in tumors, and the SIX1-EYA2 interaction has been shown to be critical for metastasis in a breast cancer model. The EYA proteins also contain protein tyrosine phosphatase activity, which plays an important role in breast cancer growth and metastasis as well as directing cells to the repair pathway upon DNA damage.

Areas covered: This review provides a summary of the SIX1/EYA complex as it relates to development and disease and the current efforts to therapeutically target this complex.

Expert opinion: Recently, there have been an increasing number of studies suggesting that targeting the SIX1/EYA transcriptional complex will potently inhibit tumor progression. Although current attempts to develop inhibitors targeting this complex are still in the early stages, continued efforts toward developing better compounds may ultimately result in effective anti-cancer therapies.

Keywords: inhibition of transcriptional complexes; metastasis; phosphatase; protein–protein interaction; six1/eyes absent complex; transcription factor.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A recreation of the Cancer Hallmarks, illustrating the known hallmarks in which the SIX1 and EYA family members carry out their tumor-promoting properties. In total, the SIX1/EYA complex has been shown to play a role in four out of the six original hallmarks, one of the two enabling characteristics and one of the two emerging hallmarks, highlighting the importance of targeting this complex as a potential therapeutic.
Figure 2
Figure 2
Surface representation illustrating the similarities between the protein interfaces of SIX1/EYA2 and two successfully targeted protein interactions, P53/MDM2 and BAK/BCL-XL. The red ribbon represents the single helix in SIX1, P53, and BAK that interacts with their corresponding protein partners in blue.
Figure 3
Figure 3
Chemical structures of the 3 series of compounds identified as inhibitors of EYA2 phosphatase activity. A. Benzbromarone and benzarone identified through the screening of a small NCI library. B. Two representative Mg2+ chelators identified through virtual screening. C. The top two allosteric N-arylidenebenzohydrazide compounds identified through a large scale HTS.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kumar JP. The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci. 2009;66(4):565–83. - PMC - PubMed
    1. Xu PX. The EYA-SO/SIX complex in development and disease. Pediatr Nephrol. 2012;28(6):843–54. - PMC - PubMed
    1. Ford HL, Kabingu EN, Bump EA, et al. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A. 1998;95(21):12608–13. This is the first study to demonstrate overexpression of SIX1 in any tumor type, and to implicate it in cell cycle control in cancer. - PMC - PubMed
    1. Li X, Oghi KA, Zhang J, et al. Eya protein phosphatase activity regulates Six1-Dach-Eya transcriptional effects in mammalian organogenesis. Nature. 2003;426(6964):247–54. One of the first studies to demonstrate that the Eya transcriptional cofactor contains intrinsic phosphatase activity, and that this may be critical for Six1-mediated transcription. - PubMed
    1. Coletta RD, Christensen K, Reichenberger KJ, et al. The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A. 2004;101(17):6478–83. - PMC - PubMed

Publication types

Substances

LinkOut - more resources